Apellis Pharmaceuticals (APLS)
(Delayed Data from NSDQ)
$37.05 USD
-0.93 (-2.45%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $37.06 +0.01 (0.03%) 6:14 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: BMO |
6/2024 | $-0.31 | 19.59% |
Earnings Summary
For their last quarter, Apellis Pharmaceuticals (APLS) reported earnings of -$0.54 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for APLS's next earnings release on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.31 per share, reflecting a year-over-year increase of 69.61%.
Earnings History
Price & Consensus
Zacks News for APLS
Apellis (APLS) Falls on Second Negative CHMP Opinion for GA Drug
APLS: What are Zacks experts saying now?
Zacks Private Portfolio Services